Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




WHO Issues New Guidelines to Reduce Surgical Infections

By Daniel Beris
Posted on 01 Dec 2016
The World Health Organization (WHO; Geneva, Switzerland) has released new global guidelines covering surgical site infection (SSI), with a view to reduce costs and infection-related patient complications.

The WHO "Global Guidelines for the Prevention of Surgical Site Infection" includes a list of 29 concrete recommendations distilled by 20 of the world’s leading experts from 26 reviews of the latest evidence. More...
Included are 13 recommendations for the period before surgery, and 16 for preventing infections during and after surgery. They range from simple precautions, such as ensuring that patients bath or shower (but not shave) before surgery, to instructions for surgical team hand hygiene compliance, what disinfectants to use before incision, and which sutures to use.

The guidelines complement the WHO “Surgical Safety Checklist”, which gives a broad range of safety measures. Importantly, the guidelines recommend that antibiotics be used to prevent infections before and during surgery only, and not after, a crucial measure in stopping the spread of antibiotic resistance, which leads to longer hospital stays, higher medical costs, and increased mortality. The recommendations were published on November 3, 2016, in The Lancet Infectious Diseases.

“No one should get sick while seeking or receiving care,” said Marie-Paule Kieny, MD, assistant director-general for health systems and innovation at the WHO. “Preventing surgical infections has never been more important, but it is complex and requires a range of preventive measures. These guidelines are an invaluable tool for protecting patients.”

“Sooner or later many of us will need surgery, but none of us wants to pick up an infection on the operating table,” said Ed Kelley, MD, director of the WHO department of service delivery and safety. “By applying these new guidelines surgical teams can reduce harm, improve quality of life, and do their bit to stop the spread of antibiotic resistance. We also recommend that patients preparing for surgery ask their surgeon whether they are following WHO’s advice.”

SSI’s are an important contributor, and may even be the most frequent healthcare-associated infection (HAI) after asymptomatic bacteriuria, representing a high burden on patients and hospitals in terms of morbidity, mortality, prolonged length of hospital stay, and additional costs. Researchers have been searching for decades for the optimal bowel preparation, but failed to address biological factors. Today, however, genome sequencing and microbiome studies have open up new areas for study that might give biological insight into what works best and for which patients.

Related Links:
World Health Organization


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.